STAT2 and breast carcinoma: ISGylation of STAT1 and STAT2 mediate clustering and nuclear relocalization of STAT1 and STAT2 within IFN-induced PML bodies and synergistically promotes the production of chemokine-receptor ligands to attract cytotoxic T cells, thereby suppressing murine breast cancer growth and metastasis.